Activest Wealth Management’s Inovio Pharmaceuticals INO Stock Holding History

Activest Wealth Management’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.65K	Hold	1,500	–	–	﹤0.01%	882
2026 Q1	$2.61K	Hold	1,500	–	–	﹤0.01%	917
2025 Q4	$2.61K	Hold	1,500	–	–	﹤0.01%	852
2025 Q3	$3.51K	Hold	1,500	–	–	﹤0.01%	703
2025 Q2	$3.05K	Hold	1,500	–	–	﹤0.01%	624
2025 Q1	$2.44K	Hold	1,500	–	–	﹤0.01%	622
2024 Q4	$2.75K	Hold	1,500	–	–	﹤0.01%	413
2024 Q3	$8.67K	Hold	1,500	–	–	﹤0.01%	332
2024 Q2	$12.1K	Buy	+1,500	New	+$15.8K	﹤0.01%	290

Other funds holding INO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Activest Wealth Management's INO Position: Q2 2026 in Review

Activest Wealth Management held its Inovio Pharmaceuticals (INO) position steady in Q2 2026 at 1,500 shares worth $1.65K. The position accounts for ﹤0.01% of the portfolio, ranked #882.

Activest Wealth Management first reported a position in INO in Q2 2024 and has held it in 9 quarters since. The position peaked at $12.1K in Q2 2024. 103 funds tracked by Wall St. Rank hold INO as of Q2 2026.

Activest Wealth Management held 1,500 shares of Inovio Pharmaceuticals worth $1.65K as of Q2 2026.
Activest Wealth Management left its Inovio Pharmaceuticals share count unchanged in Q2 2026.
Inovio Pharmaceuticals made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #882 holding.
Activest Wealth Management first reported a position in Inovio Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
Activest Wealth Management's Inovio Pharmaceuticals position peaked at $12.1K in Q2 2024.
103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.